Does ONDANSETRON Cause Second primary malignancy? 30 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 30 reports of Second primary malignancy have been filed in association with ONDANSETRON (ONDANSETRON). This represents 0.1% of all adverse event reports for ONDANSETRON.
30
Reports of Second primary malignancy with ONDANSETRON
0.1%
of all ONDANSETRON reports
12
Deaths
22
Hospitalizations
How Dangerous Is Second primary malignancy From ONDANSETRON?
Of the 30 reports, 12 (40.0%) resulted in death, 22 (73.3%) required hospitalization, and 5 (16.7%) were considered life-threatening.
Is Second primary malignancy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ONDANSETRON. However, 30 reports have been filed with the FAERS database.
What Other Side Effects Does ONDANSETRON Cause?
Nausea (2,986)
Vomiting (1,990)
Off label use (1,905)
Drug ineffective (1,856)
Pain (1,666)
Constipation (1,596)
Foetal exposure during pregnancy (1,571)
Pyrexia (1,555)
Maternal exposure during pregnancy (1,503)
Fatigue (1,440)
What Other Drugs Cause Second primary malignancy?
CYCLOPHOSPHAMIDE (1,247)
DOXORUBICIN (1,151)
VINCRISTINE (908)
IMATINIB (763)
PALBOCICLIB (658)
RITUXIMAB (646)
RUXOLITINIB (611)
ETOPOSIDE (573)
PREDNISONE (517)
OCTREOTIDE (496)
Which ONDANSETRON Alternatives Have Lower Second primary malignancy Risk?
ONDANSETRON vs ONFI
ONDANSETRON vs OPANA
ONDANSETRON vs OPICAPONE
ONDANSETRON vs OPIPRAMOL
ONDANSETRON vs OPIUM